招銀國際:維持特步國際(1368.HK)買入評級 目標價升至16.32港元
招銀國際發表報吿,上調特步國際(1368.HK)目標價至16.32港元,維持買入投資評級。
報吿指,對特步於2021年下半年和2022年之零售和訂單展望正面,預期將保持快速增長,而目前,特步庫存水平健康及零售折扣改善。該行認為,國內服裝品牌有龐大增長空間,而公司持續多年投資於產品功能、設計和創新,以及本地化市場推廣,有助推動銷售增長。
報吿又預期,核心特步品牌於2020-23年之銷售/純利年均複合增長達10-15%/15-20%。故上調特步2021/22/23年每股盈利預測,以反映勝預期的銷售、毛利率和經營槓桿。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.